Proteostasis Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch PTI and buy or sell other stocks, ETFs, and their options commission-free!

About PTI

Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb. 

CEO
Shawn P. Iadonato, PhD
CEOShawn P. Iadonato, PhD
Employees
5
Employees5
Headquarters
Mercer Island, Washington
HeadquartersMercer Island, Washington
Founded
2008
Founded2008
Employees
5
Employees5

PTI Key Statistics

Market cap
25.59M
Market cap25.59M
Price-Earnings ratio
-0.39
Price-Earnings ratio-0.39
Dividend yield
—
Dividend yield—
Average volume
10.40K
Average volume10.40K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.15
52 Week high$1.15
52 Week low
$0.1921
52 Week low$0.1921

People also own

Based on the portfolios of people who own PTI. This list is generated using Robinhood data, and it’s not a recommendation.
iBio
Ocugen, Inc
Onconova Therapeutics
Inpixon
Oragenics
Matinas BioPharma
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.